BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare CNS Disease Analysis: Schizophrenia

December 15, 2020

Schizophrenia is a serious mental illness characterized by incoherent thoughts, bizarre behavior, and delusions or hallucinations. The American Psychiatric Association defines schizophrenia as a chronic brain disorder, which actively presents with delusions, hallucinations, lack of motivation, and issues with thinking and concentration. Schizophrenia is a psychotic disorder that typically first presents in adolescence and young adulthood. The condition is associated with a prodromal period that can last for months or years, during which emotional, behavioral, and attenuated psychotic symptoms first appear. The functional consequences of schizophrenia confer prominent social and occupational dysfunction. The disorder substantially hinders educational progress, employment, and the extent of social contact.

This Datamonitor Healthcare report contains a Disease Analysis module.

Indications Covered: Schizophrenia
Back to the top Back to the top